acidest
new
type
quercetin
deriv
success
prepar
first
time
differ
quercetin
novel
compound
show
higher
select
inhibitor
src
tyrosin
kinas
ic
valu
rang
mm
mm
egfr
tyrosin
kinas
molecular
dock
reveal
hydrophob
hydrogen
bond
interact
import
select
therefor
studi
provid
new
promis
scaffold
develop
new
anticanc
drug
target
src
tyrosin
kinas
quercetin
water
solubl
flavanoid
deriv
amelior
effect
host
disord
includ
cancer
renal
cardiovascular
diseas
inhibitori
activ
sarscov
pro
viral
replic
particularli
quercetin
wellknown
protein
tyrosin
kinas
ptk
inhibitor
micromolar
level
instanc
ic
valu
mm
epiderm
growth
factor
receptor
egfr
mm
src
tyrosin
kinas
respect
indic
natur
product
activ
egfr
src
tyrosin
kinas
last
decad
consider
interest
synthesi
function
elucid
biolog
evalu
quercetin
deriv
studi
focus
quercetin
oglycosid
major
sugar
linkag
acidest
neither
discov
natur
product
report
synthesi
bioactiv
studi
therefor
whether
type
compound
could
synthes
whether
still
activ
ptk
remain
unknown
ptk
catalyz
phosphoryl
transfer
gphosphoryl
group
atp
tyrosin
residu
protein
play
central
role
signal
transduct
cellular
mechan
one
import
ptk
egfr
ligand
egf
tgfa
found
high
express
level
mani
tumor
epitheli
origin
prolif
disord
epidermi
psoriasi
src
nonreceptor
tyrosin
kinas
function
earli
upstream
signal
transduct
protein
activ
sever
human
cancer
includ
carcinoma
breast
lung
colon
esophagu
skin
parotid
cervix
well
gastric
tissu
therefor
attract
target
discoveri
antitumor
drug
paper
report
first
attempt
synthes
seri
novel
acidest
remark
compound
synthes
also
show
promis
high
select
inhibitori
activ
src
tyrosin
kinas
primari
structureact
relationship
new
compound
elucid
molecular
model
well
prepar
varieti
quercetin
deriv
variou
substitu
effici
facil
synthesi
approach
develop
depict
scheme
straightforward
threestep
synthet
rout
allow
us
diversifi
posit
quercetin
moieti
via
key
intermedi
later
stage
begin
commerci
avail
rutin
protect
hydroxyl
group
subsequ
deglycosyl
led
select
protect
quercetin
gave
entri
seri
substitut
posit
inde
compound
still
exhibit
two
free
hydroxyl
group
howev
higher
reactiv
posit
allow
select
esterif
protect
amino
acid
thf
use
equiv
dcc
n
ndicyclohexylcarbodiimid
condens
agent
littl
dmap
catalyst
cleavag
benzyl
group
perform
hydrogenolysi
catalyz
pdc
desir
final
product
acidest
obtain
good
yield
purif
chromatographi
substitut
n
atom
amino
acid
moieti
import
first
approach
get
compound
bear
deprotect
amino
group
amino
acid
moieti
trifluoroacet
acid
solut
dichloromethan
use
remov
tertbutyloxycarbonyl
group
scheme
howev
desir
product
detect
crude
product
conjectur
target
compound
decompos
acid
medium
altern
approach
perform
mild
condit
investig
scheme
unfortun
attempt
debenzyl
compound
bear
benzyl
n
atom
amino
acid
moieti
h
atmospher
ambient
temperatur
success
base
studi
deduc
compound
without
protect
group
n
atom
unstabl
besid
tri
synthes
compound
bear
bocser
acgli
acthr
intermedi
debenzyl
obtain
moder
yield
howev
desir
product
detect
crude
product
debenzyl
termin
addit
ml
h
plate
read
use
multiwal
spectrophotomet
molecular
devic
sunnyval
ca
usa
nm
inhibit
rate
calcul
use
follow
equat
control
ic
valu
calcul
inhibit
curv
explor
interact
mechan
newli
synthes
acidest
two
target
molecular
dock
carri
program
autodock
compound
bind
src
egfr
respect
three
dimension
structur
target
protein
human
csrc
egfr
brookhaven
protein
data
bank
pdb
entri
respect
lamarckian
genet
algorithm
lga
use
dock
follow
set
maximum
number
energi
evalu
initi
popul
randomli
place
individu
maximum
number
gener
mutat
rate
crossov
rate
elit
valu
number
top
individu
automat
surviv
adapt
local
search
method
pseudosoli
wet
algorithm
appli
maximum
iter
per
search
valid
reliabl
dock
approach
paramet
use
bind
free
energi
quercetin
egfr
src
kinas
calcul
paramet
primari
assay
percent
inhibit
compound
mm
measur
data
list
tabl
remark
newli
synthes
acidest
show
low
inhibit
egfr
kinas
wherea
exhibit
inhibitori
activ
high
src
kinas
tabl
result
suggest
novel
acidest
higher
inhibitori
select
src
kinas
egfr
kinas
thu
introduct
amino
acid
group
quercetin
lead
revers
high
inhibitori
select
egfr
src
confirm
bioactiv
ic
valu
determin
compound
inhibit
rate
higher
src
kinas
mm
name
compound
tabl
data
show
compound
promin
inhibitori
activ
ic
valu
rang
mm
mm
indic
acidest
moder
activ
inhibitor
src
kinas
bind
free
energi
quercetin
egfr
src
kinas
calcul
kcalmol
kcalmol
respect
good
agreement
experiment
result
quercetin
activ
egfr
src
kinas
therefor
dock
approach
paramet
reason
reliabl
predict
bind
free
energi
dg
new
compound
list
tabl
notic
predict
dg
valu
new
compound
src
kinas
kcalmol
averag
stronger
kcalmol
egfr
kcal
mol
averag
agreement
experiment
observ
new
compound
stronger
inhibitor
src
kinas
egfr
kinas
therefor
select
newli
synthes
acidest
attribut
specif
properti
substitut
r
group
amino
acid
tabl
differ
conform
found
compound
activ
pocket
protein
comparison
differ
bind
mechan
pair
hydrophob
interact
hi
hereinaft
number
hydrogen
bond
hb
hereinaft
new
compound
two
target
analyz
program
ligplot
result
reveal
averag
hb
src
new
compound
averag
hb
egfr
compound
tabl
fig
supplementari
materi
word
one
third
two
kind
interact
observ
compound
src
kinas
egfr
kinas
exampl
interact
detail
two
activ
compound
shown
fig
atom
form
hydrophob
interact
residu
src
atom
newli
substitut
group
fig
atom
form
hydrophob
interact
residu
egfr
atom
substitut
group
fig
two
hydrogen
bond
form
src
hb
compound
egfr
regard
bind
hydrophob
interact
src
similar
egfr
hb
src
egfr
therefor
hydrophob
hydrogen
bond
interact
import
high
select
novel
acidest
src
kinas
summari
first
time
fifteen
novel
acidest
deriv
success
prepar
studi
bioassay
reveal
new
compound
higher
select
inhibitor
src
kinas
egfr
kinas
differ
quercetin
activ
egfr
src
molecular
dock
result
reveal
hydrophob
hydrogen
bond
interact
import
select
averag
one
third
two
kind
interact
observ
compound
src
kinas
egfr
kinas
therefor
studi
provid
new
promis
scaffold
moder
inhibitori
activ
ic
valu
rang
mm
mm
develop
new
anticanc
drug
target
src
tyrosin
kinas
reagent
chemic
purchas
commerci
sourc
alfa
gl
biochem
ltd
shanghai
chemic
reagent
compani
use
without
purif
analyt
thin
layer
chromatographi
tlc
hsgf
mm
thick
yantai
huiyou
compani
china
column
chromatographi
perform
combiflash
companion
system
teledyn
isco
inc
nmr
spectra
obtain
varian
spectromet
tm
chemic
shift
report
part
per
million
ppm
downfield
tetramethylsilan
proton
coupl
pattern
describ
singlet
doublet
triplet
quartet
q
multiplet
broad
br
lowand
highresolut
mass
spectra
lrm
hrm
given
electr
electrospray
ioniz
ei
esi
produc
finnigan
lcqdeca
spectromet
mixtur
rutin
g
mmol
k
co
g
mmol
anhydr
dmf
ml
stir
nitrogen
h
benzyl
bromid
ml
mmol
ad
stir
h
c
mixtur
acidifi
ph
acoh
mixtur
compound
mg
mmol
dcc
mg
mmol
dmap
mg
mmol
bocleuoh
h
mg
mmol
thf
ml
stir
ambient
temperatur
h
mixtur
filter
filtrat
purifi
flash
column
chromatographi
ch
cl
ch
oh
give
form
product
mixtur
etohdioxan
ml
ad
palladium
carbon
mg
mixtur
stir
h
atmospher
ambient
temperatur
h
result
mixtur
filter
celit
wash
etoh
purifi
flash
column
chromatographi
tabl
ic
valu
mm
predict
bind
free
energi
dg
kcalmol
procedur
describ
use
start
ac
